BridgeBio's pipeline assets like encaleret and BBP-418 offer optionality but lack near-term cash flow and face regulatory ...

The High Plains Dairy Conference returns to Amarillo in March 2026, offering producers critical insights into global markets, labor tech and biosecurity to navigate a high-stakes industry.

Global calcium gluconate demand accelerates as pharmaceutical usage, healthcare expansion, and emerging markets drive sustained industry growth. NEWARK, DELAWARE / ACCESS Newswire / February 10, 2026 ...

“Sully ingested a medication used in animals and humans for hypertension and arrhythmias (irregular heartbeat) called ...

A companion diagnostic test was simultaneously approved to identify eligible patients whose tumors express PD-L1 with a combined positive score of 1 or higher.

When you're in love, your heart can race, and you can feel like your blood pressure is through the roof. While that's ...

FDA clearance covers pembrolizumab plus paclitaxel ± bevacizumab for PD-L1 CPS ≥1 platinum-resistant disease after one or two prior systemic regimens, introducing PD-1 inhibition into this treatment ...

In a consensus statement issued by the European Renal Association and published online Nov. 28 in Nephrology Dialysis ...

In a consensus statement, recommendations are presented for the management of skeletal fragility in patients with chronic kidney disease.

BridgeBio unveiled promising results Thursday for its "hotly debated" final-phase asset: a potential treatment for ...

Fluid, electrolyte and mineral perturbations are prevalent features of tropical disease. Hemodynamic alterations, fever, nitrogen wasting, and changes in membrane transport and acid–base balance ...